Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1455-2025

CooperVision, Inc. recalls Brand Names: MyDay Toric

CooperVision, Inc.West Henrietta, NY, United StatesReported Apr 2, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

a limited number of lots were manufactured with an incorrect cylinder power.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Brand Names: MyDay Toric, LensCrafters One Day Premium Daily Disposable Contact Lenses For Astigmatism, Pearle Vision 1 Day Premium For Astigmatism, REVEAL 1-DAY TORIC, Vision Source Reveal Toric, Voyant 1-Day Premium Toric. Brand Names (OUS only): CADENCE DELUXE 1-DAY TORIC, DUBLAN PREMIUM OXYGEN 1 DAY TORIC, EV LINARIAL TORIC (30), EYEXPERT PURE ASTIGMATISM (30), LENTI!!AS A ASTIGMATISMO 30PK, LENTSOFT DIARIA CONFORT+ SILICONA ASTIGMATISMO, MULTILENS CONTACT ELITE SILICONE 1 DAY TORICS, OPTIONS SUPREME 1 DAY TRC (30), PRIMA + 1 DAY ASTGM (30), PROTECT PLATINUM FOR ASTG (30), SOL- LENS 1 DAY SILICONE PREMIUM TORIC, UGO LENS DAY ADVANCED TORICA, WHITE BOX STENFILCON A TORIC 07536, MEDIFLEX SUP 1D TORIC, Kirkland Signature Toric Premium Daily Disposable, Specsavers easyvision Linarial Toric. Product Name: (Stenfilcon A) Contact Lens Model/Catalog Number: MyDay Toric Product Description: 54% water content, Toric, cast moulded Silicone Hydrogel, In-monomer tinted, contact lens, for Daily Disposable Wear. Blister packaged. Component: No
    15 affected lots
    6461501582646150159064485022356472500679193465025950283444465001171934650261321455502575
    +7 more21476504025215455028132412750223540702500019215125013312149250165321492501685

What the firm is doing

On February 27, 2025, URGENT MEDICAL DEVICE CORRECTION letters were sent to direct consignees. We request you take the following actions: 1. Please examine your inventory/product shelf for any of the provided affected lot numbers. The lot number can be found on the back panel of the carton below the expiration date. (Carton lots 19346502595028, 19346502613028, 21545502813013, and 21512501331524) 2. While trials lenses are not impacted by this action, if your patients have discarded the carton, the affected product can be identified by examining the lot number printed on the blister. This number is different from the carton lot number. (Blister lots 6461501582, 6461501590, 6448502235, 6472500679) The lot number can be found on the front of the blister label below the expiration date. Below is an example and where to locate the lot number on both a carton and blister. Stop any further distribution of product from the designated lot numbers; 3. We recommend authorized distributors contact your accounts and Eye Care Practitioners contact your patients who have received the affected product with the enclosed draft Consumer Communication Letter, to be completed by the Eye Care Practitioner s office. 4. Please instruct any patients to return any affected product to their Eye Care Practitioner for replacement or credit. 5. Within the next five (5) business days, please complete the attached Correction Response Form and fax it to 888-385-3217 or scan and email to: info@coopervision.com. If you have no lenses from these specified lots, please put 0 in Quantity ; 6. Dispose of the affected product in your inventory or that is returned to you. 7. Your account will be credited once the form is received. 8. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting Program, either online, by regular mail, or by fax. 9. If your patients have questions or complaints, please have them contact our cu

DistributionShow details

Domestic: CA, CO, FL, IL, KY, MI, NC, NE, NJ, NY, OH, OR, UT, VA, WA. International: Australia, Belgium, Canada, Czech Republic, Denmark, France, Germany, Ireland, Italy, Luxembourg, Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and United Kingdom.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls